Major drugmaker Eisai Co. said Wednesday it will recall a cough medicine and expectorant in view of an erroneous description in the directions inside the package.
Subject to the recall are 93,080 packages of SKAINAR capsules manufactured between May 2000 and this month, the company said.
The erroneous directions recommend that users consult doctors or pharmacists “in the event that patients’ symptoms do not ease even after taking the medicine for five to six days,” it said.
The directions should have said that users should consult doctors or pharmacists “in the event that patients’ symptoms do not ease even after taking the medicine five to six times.”
The medicine packages in question carry one of four manufacturing identification numbers: 05A10K, 17B65K, 2YA97K and 2YA98K.
In a time of both misinformation and too much information, quality journalism is more crucial than ever.
By subscribing, you can help us get the story right.